Bowel Screening

Provision of bowel cancer screening endoscopy services, primarily colonoscopy procedures, delivered in support of the NHS Bowel Cancer Screening Programme. The contract has been awarded under the Provider Selection Regime Direct Award Process C to ensure continuity of clinically safe and effective screening services.

This procurement relates to the provision of bowel cancer screening endoscopy services primarily colonoscopy procedures delivered as part of the NHS Bowel Cancer Screening Programme. The services support the early detection of bowel cancer and the identification and removal of pre‑cancerous lesions in line with national screening standards.
The contract has been awarded under the Provider Selection Regime Direct Award Process C as the existing provider is delivering the services to a satisfactory standard and continuity of clinically safe, effective, and accessible screening services is required. the lifetime of the service is to be 1 year at a cost of £142,594.40 and will begin 01.08.26 - 31.07.26. Additional information: Maintaining uninterrupted access to bowel screening is essential for patient pathways, early detection rates, and overall service outcomes. The PSR statutory guidance highlights that continuity of service, particularly in regulated clinical pathways, is a key consideration in determining the most suitable procurement route.
The current providers at Saxon Clinic and Chiltern Clinic are already integrated into the screening pathway, workforce arrangements, booking systems, and reporting processes. Any cessation or change of provider would create gaps in delivery, resulting in cancelled appointments and reduced screening throughput.
Therefore, continuity of service was essential and supported use of Direct Award C
This contract has been awarded under
the provision of the Provider Selection
Regime (PSR).

This contract has been
awarded under the Health Care
Services (Provider Selection Regime)
regulations 2023. For the avoidance of
doubt, the provision of the Public
Contracts Regulations 2015 do not
apply to this award.
The award of contract is to Circle
Health - Circle Health Group
1st Floor
30 Cannon Street
LONDON
EC4 M6X
Sub-Contract Reference Circle Health
Holdings H2 2023-2024
Direct Award C requires publication of a
notice of intention to award on the UK e
notification service, followed by an 8
working day standstill period, before
contract award.
MKUH has followed or will follow this
process in line with the PSR
transparency and accountability
requirements.
The award of contract is for 12 months.
Conflicts of interest identified among
the MKUH evaluators were none. The
ono conflicted members have assessed
the nature and risk of this conflict, and
have decided which steps to take to
avoid or manage it.
An evaluation using the PSR template
has been completed and agreed by all
evaluators.
Representations by providers must be
made to decision makers by [Add date].

This contract has not yet formally been
awarded; this notice serves as an
intention to award under the PSR.
Lisa.howe@mkuh.nhs.uk - responses
can be received here with the subject
title FTS-019926.
The 5 key criteria have been assessed
of 1. Quality and Innovation. 2. Value.
3. Intergration and collaboration. 4.
Improving access. 5. Social value.
This is a Provider Selection Regime
(PSR) intention to award notice. The
awarding of this contract is subject to
the Health Care Services (Provider Selection Regime) Regulations 2023.
For the avoidance of doubt, the
provisions of the Public Contracts
Regulations 2015 do not apply to this
award. The standstill period begins on
the day after the publication of this
notice. Representations by providers
must be made to the relevant authority
by [Add date].

This contract has not yet
formally been awarded; this notice
serves as an intention to award under
the PSR